pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,065 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 21 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×type: phase readout×clear all
type
  • phase readout5,063
  • 8k filing2,335
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07545486: Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment

    Sponsor: Chirec. Phase: . Conditions: Solid Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05835986: A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus

    Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06716086: A Novel Shape Memory Alloy-Based Orthosis for Proximal Interphalangeal Joint Stiffness

    Sponsor: National Cheng-Kung University Hospital. Phase: NA. Conditions: Finger Proximal Interphalangeal Joint Contracture

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04285086: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

    Sponsor: PharmaEssentia. Phase: PHASE3. Conditions: Essential Thrombocythemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07442773: Intervention to Support Partners and Informal Caregivers of Frail RA-patients

    Sponsor: Glostrup University Hospital, Copenhagen. Phase: NA. Conditions: Rheumatic Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07382869: to Investigate Impact of Diet and Physical Activity Based Nurse Led Interventions on Maternal Outcomes and Neonatal Outcomes in Women With Gestational Diabetes Mellitus (GDM)

    Sponsor: University of Health Sciences Lahore. Phase: NA. Conditions: Gestatiaonl Diabetes Mellitus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03970083: A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer

    Sponsor: Brigham and Women's Hospital. Phase: . Conditions: Gynecologic Cancer, Cervical Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04777383: The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow

    Sponsor: University Hospital, Linkoeping. Phase: NA. Conditions: Cardiovascular Diseases, Vascular Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06710483: A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities

    Sponsor: Boston University. Phase: NA. Conditions: Intellectual Disability, Variable

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT02707341: The CorEvitas Psoriasis (PSO) Registry

    Sponsor: CorEvitas. Phase: . Conditions: Psoriasis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06395441: Wisconsin Ginseng for Decreasing Cancer Related Fatigue

    Sponsor: Mayo Clinic. Phase: PHASE3. Conditions: Malignant Solid Neoplasm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04054154: An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02688894: The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

    Sponsor: Samsung Medical Center. Phase: . Conditions: Small Cell Lung Cancers, Neuroendocrine Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03394066: Mechanism of Non-invasive Magnetic Stimulation

    Sponsor: National Institute on Drug Abuse (NIDA). Phase: NA. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07338994: TENS With Proprioceptive-Visual Training on Gait Parameters in CP

    Sponsor: Cairo University. Phase: NA. Conditions: Cerebral Palsy (CP)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06308822: Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07676929: Clinical Evaluation of 3D-Printed Versus Semi-Direct Composite Resin Restorations

    Sponsor: Tanta University. Phase: NA. Conditions: Composite Restoration, 3D Printing, Posterior Teeth, Semi-direct Restoration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07338929: Physical Performance Assessment in Kidney Transplant Evaluation

    Sponsor: University Hospital, Martin. Phase: . Conditions: Frailty Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07634731: Bilateral RSB vs TEA Epidural Analgesia for Postoperative Pain Control After Open Gastrectomy: A Randomized Controlled Trial

    Sponsor: Igors Ivanovs. Phase: NA. Conditions: Bilateral Rectus Sheath Block, Thoracic Epidural Analgesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07546331: Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

    Sponsor: University of California, San Francisco. Phase: . Conditions: Breast Carcinoma, Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02729402: Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults

    Sponsor: University of Utah. Phase: NA. Conditions: Dementia, Hearing Loss, Presbycusis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07585929: Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix

    Sponsor: All India Institute of Medical Sciences. Phase: NA. Conditions: Stage IIIC

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06831929: HPV Ends Here: Increasing Uptake of the HPV Vaccine

    Sponsor: University of California, Davis. Phase: NA. Conditions: HPV Vaccine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07591337: SNRK & Vascular Endothelial Aging

    Sponsor: Tianjin Medical University. Phase: . Conditions: Vascular Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06320717: AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma

    Sponsor: Roswell Park Cancer Institute. Phase: . Conditions: Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06040840: WALANT Versus Axillary Brachial Plexus Block in Carpal Tunnel Release

    Sponsor: CMC Ambroise Paré. Phase: NA. Conditions: Carpal Tunnel Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07386340: Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

    Sponsor: Senseonics, Inc.. Phase: NA. Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06810440: Reducing Anemia Among Preconception Women in Nepal Through a Group Norm and Micronutrient Supplementation Intervention

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Anemia, Iron-Deficiency, Nutritional Deficiencies, Adherence, Norms, Social, Knowledge, Attitudes, Practice

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07347340: Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve

    Sponsor: Peking Union Medical College Hospital. Phase: PHASE3. Conditions: Diminished Ovarian Reserve (DOR)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06739668: Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Post-Acute COVID-19 Syndrome, Cognitive Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06915168: CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

    Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06830850: A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

    Sponsor: Atridia Pty Ltd.. Phase: PHASE1. Conditions: Metastatic Castration Resistant Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07662291: Frequency Effects of Transcutaneous Trigeminal Nerve Stimulation (eTNS) on Brain and Autonomic Function

    Sponsor: Xidian University. Phase: NA. Conditions: Healthy Volunteers, fMRI Research

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07545174: Role of the Environment in Pediatric Obesity

    Sponsor: University Hospital, Tours. Phase: NA. Conditions: Obesity (Disorder)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02545374: Medico-economic Evaluation of a Project of Wounds by a Remote Network

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Resident of Languedoc-roussillon, Carrying a Chronic Wound

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05898074: Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery

    Sponsor: Indiana University. Phase: NA. Conditions: Skull Base Neoplasms, Cerebrospinal Fluid Leakage, Nasal; Hypertrophy, Mucous Membrane (Septum)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03803774: Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Sinonasal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05676697: PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07573202: Evaluation of Hypersensitivity Reactions to Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh in Shoulder Surgery

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Hypersensitivity Reactions, Allergic Contact Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06353802: Relationship Between Chronic Non-Specific Neck Pain And Lumbar Reposition Sense

    Sponsor: Cairo University. Phase: NA. Conditions: Chronic Non-specific Neck Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07029802: Development of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury

    Sponsor: University of Minnesota. Phase: . Conditions: Spinal Cord Injuries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05774002: Psychological Assessment of Scoliosis Patients Undergoing Surgical Management

    Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Adolescent Idiopathic Scoliosis (AIS), Mental Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07087002: GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

    Sponsor: Stanford University. Phase: PHASE1. Conditions: Medulloblastoma, Central Nervous System Embryonal Tumor, Refractory Medulloblastoma, Recurrent Medulloblastoma, Pediatric Brain Tumor, Embryonal Tumor With Multilayered Rosettes (ETMR), Pineoblastoma, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS, CNS Neuroblastoma, FOXR2-activated

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07709637: Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

    Sponsor: LucasBio. Phase: PHASE1. Conditions: COVID-19, COVID-19 (SARS-CoV-2 Infection)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06430437: A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations

    Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer With HER2- Mutations

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06311045: Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Obstructive Sleep Apnea

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07547345: Mobilizing Community Hypertension Access Pilot

    Sponsor: Rush University Medical Center. Phase: NA. Conditions: Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06690372: Improving Heart Health in Individuals With SCI Using Home-Based Virtual Gaming

    Sponsor: Drexel University. Phase: NA. Conditions: Spinal Cord Injuries (SCI)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05547672: Clinical Investigation to Assess a New Artificial Urinary Sphincter to Treat Urinary Incontinence in Men

    Sponsor: UroMems SAS. Phase: NA. Conditions: Urinary Incontinence,Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03738072: Intracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Epilepsy

    full page →ctgov ↗
    ← prev
    page 94 of 102
    next →